The small ligands IMMS activate both TLR7 and TLR8 similarly to the natural pathogens to yield a cascade of biochemical events that initially stimulate several type of cells, such as monocytes and NK/NKT, T, B, mast and tumor cells. This evidence concerns the gene TLR7 and neoplasm.